(Q38994370)

8 September 2017

1 reference

title

Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift (English)

1 reference

8 September 2017

Alberto da Silva Moraes

0 references

author name string

Felipe Andrés Cordero Luz

1

1 reference

8 September 2017

Paula Cristina Brígido

2

1 reference

8 September 2017

Alberto Silva Moraes

3

1 reference

8 September 2017

Marcelo José Barbosa Silva

4

1 reference

8 September 2017

29 October 2016

1 reference

8 September 2017

1 reference

8 September 2017

92

1 reference

8 September 2017

1

1 reference

8 September 2017

3-13

1 reference

Hallmarks of Cancer: The Next Generation

8 September 2017

1 reference

Cancer-associated regulation of alternative splicing

21 January 2018

1 reference

Epithelial-mesenchymal transition-related factors in solid tumor and hematological malignancy

21 January 2018

1 reference

The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion

21 January 2018

1 reference

Splicing programs and cancer

21 January 2018

1 reference

An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype

21 January 2018

1 reference

RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.

21 January 2018

1 reference

The spliceosome: design principles of a dynamic RNP machine

21 January 2018

1 reference

Aberrant and alternative splicing in cancer

21 January 2018

1 reference

Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing

21 January 2018

1 reference

Alternative splicing in cancer: noise, functional, or systematic?

21 January 2018

1 reference

Deregulation of splicing factors and breast cancer development.

21 January 2018

1 reference

Aberrant RNA splicing and its functional consequences in cancer cells

21 January 2018

1 reference

MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation.

21 January 2018

1 reference

Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin.

21 January 2018

1 reference

Identification of recurrent regulated alternative splicing events across human solid tumors

21 January 2018

1 reference

The gene encoding the splicing factor SF2/ASF is a proto-oncogene

21 January 2018

1 reference

Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer

21 January 2018

1 reference

Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition

21 January 2018

1 reference

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

21 January 2018

1 reference

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

21 January 2018

1 reference

TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.

21 January 2018

1 reference

Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases

21 January 2018

1 reference

TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition

21 January 2018

1 reference

The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells

21 January 2018

1 reference

Γ-Ionizing radiation-induced activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate

21 January 2018

1 reference

Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells

21 January 2018

1 reference

HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition

21 January 2018

1 reference

EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC

21 January 2018

1 reference

Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene.

21 January 2018

1 reference

The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events

21 January 2018

1 reference

Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.

21 January 2018

1 reference

Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition

21 January 2018

1 reference

Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication

21 January 2018

1 reference

Exploring mechanisms of FGF signalling through the lens of structural biology

21 January 2018

1 reference

Fibroblast growth factor receptor 2 IIIc as a therapeutic target for colorectal cancer cells

21 January 2018

1 reference

Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer.

21 January 2018

1 reference

Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer

21 January 2018

1 reference

Identification of FGF receptor-binding peptides for cancer gene therapy

21 January 2018

1 reference

Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity

21 January 2018

1 reference

Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.

21 January 2018

1 reference

Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells

21 January 2018

1 reference

Selective activation of p120ctn-Kaiso signaling to unlock contact inhibition of ARPE-19 cells without epithelial-mesenchymal transition

21 January 2018

1 reference

TGF-β1 and FGF2 stimulate the epithelial-mesenchymal transition of HERS cells through a MEK-dependent mechanism.

21 January 2018

1 reference

Chromosomal Rearrangements in Cancer: Detection and potential causal mechanisms

21 January 2018

1 reference

Causes and consequences of aneuploidy in cancer.

21 January 2018

1 reference

The influence of subclonal resistance mutations on targeted cancer therapy

21 January 2018

1 reference

Exon-level microarray analyses identify alternative splicing programs in breast cancer

21 January 2018

1 reference

Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000450650

1 reference

8 September 2017

1 reference